Maze Therapeutics Statistics

Total Valuation

MAZE has a market cap or net worth of $499.06 million. The enterprise value is $429.49 million.

Market Cap	499.06M
Enterprise Value	429.49M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

MAZE has 43.78 million shares outstanding. The number of shares has increased by 17.86% in one year.

Current Share Class	43.78M
Shares Outstanding	43.78M
Shares Change (YoY)	+17.86%
Shares Change (QoQ)	-25.78%
Owned by Insiders (%)	1.48%
Owned by Institutions (%)	0.82%
Float	18.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.54
Forward PS	n/a
PB Ratio	5.03
P/TBV Ratio	n/a
P/FCF Ratio	6.48
P/OCF Ratio	6.43
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.33, with an EV/FCF ratio of 5.56.

EV / Earnings	n/a
EV / Sales	2.56
EV / EBITDA	6.33
EV / EBIT	6.68
EV / FCF	5.56

Financial Position

The company has a current ratio of 8.77, with a Debt / Equity ratio of 0.80.

Current Ratio	8.77
Quick Ratio	8.52
Debt / Equity	0.80
Debt / EBITDA	1.09
Debt / FCF	1.03
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	36.74%
Revenue Per Employee	$1.38M
Profits Per Employee	-$150,959
Employee Count	121
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, MAZE has paid $1.45 million in taxes.

Income Tax	1.45M
Effective Tax Rate	2.55%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	37.61
Average Volume (20 Days)	186,613

Short Selling Information

The latest short interest is 1.20 million, so 2.73% of the outstanding shares have been sold short.

Short Interest	1.20M
Short Previous Month	n/a
Short % of Shares Out	2.73%
Short % of Float	6.49%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MAZE had revenue of $167.50 million and -$18.27 million in losses. Loss per share was -$0.80.

Revenue	167.50M
Gross Profit	167.50M
Operating Income	64.26M
Pretax Income	-16.82M
Net Income	-18.27M
EBITDA	67.83M
EBIT	64.26M
Loss Per Share	-$0.80

Full Income Statement

Balance Sheet

The company has $149.61 million in cash and $79.16 million in debt, giving a net cash position of $70.45 million or $1.61 per share.

Cash & Cash Equivalents	149.61M
Total Debt	79.16M
Net Cash	70.45M
Net Cash Per Share	$1.61
Equity (Book Value)	99.37M
Book Value Per Share	-12.15
Working Capital	136.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $77.76 million and capital expenditures -$576,000, giving a free cash flow of $77.19 million.

Operating Cash Flow	77.76M
Capital Expenditures	-576,000
Free Cash Flow	77.19M
FCF Per Share	$1.76

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of 38.36% and 32.97%.

Gross Margin	100.00%
Operating Margin	38.36%
Pretax Margin	33.84%
Profit Margin	32.97%
EBITDA Margin	40.49%
EBIT Margin	38.36%
FCF Margin	46.08%

Dividends & Yields

MAZE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.86%
Shareholder Yield	-17.86%
Earnings Yield	-3.65%
FCF Yield	15.44%

Analyst Forecast

The average price target for MAZE is $25.67, which is 125.18% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$25.67
Price Target Difference	125.18%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

MAZE has an Altman Z-Score of 0.54 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.54
Piotroski F-Score	3